Applied NeuroSolutions CEO Dr. John DeBernardis Discusses Alzheimer's Research And Corporate Strategy With PRBroadcast.com.VERNON HILLS, Ill. -- Applied NeuroSolutions, Inc (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :APNS APNS All Pakistan Newspapers Society APNS Alliance to Protect Nantucket Sound ) (www.appliedneurosolutions.com) today announced that the Company is presently featured in an online interview at www.PrBroadcast.com. CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Dr. John DeBernardis discusses the Company's recent Alzheimer's research and findings as well as other matters impacting the future performance of the company. The Applied NeuroSolutions, Inc. interview with Dr. DeBernardis is available at http://www.PRBroadcast.com. To access the interview, click on "Join Now/Log In" in the upper right corner. After providing your name, e-mail address See Internet address. e-mail address - electronic mail address , and creating a password; click on the "send" button at the top of the page. This will register you and send you back to the PRBroadcast.com home page. You may access any CEO Interview or Company name by "trading symbol Trading symbol See: Ticker symbol " (APNS) or Company name located in the upper left portion of the PRBroadcast.com web page. About Applied NeuroSolutions, Inc Applied NeuroSolutions, Inc. is developing products to diagnose and treat Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. based on a novel hypothesis of AD cause and pathology. In partnership with Dr. Peter Davies and a scientific team at Albert Einstein College of Medicine
The Albert Einstein College of Medicine (AECOM) is a graduate school of Yeshiva University. It is a private medical school located in the Jack and Pearl Resnick Campus of Yeshiva University in the Morris Park , Applied NeuroSolutions has developed a cerebrospinal fluid cerebrospinal fluid (CSF) Clear, colourless liquid that surrounds the brain and spinal cord and fills the spaces in them. It helps support the brain, acts as a lubricant, maintains pressure in the skull, and cushions shocks. (CSF Cerebrospinal Fluid (CSF) Analysis Definition Cerebrospinal fluid (CSF) analysis is a laboratory test to examine a sample of the fluid surrounding the brain and spinal cord. ) test to detect Alzheimer's disease at a very early stage with 85%-95% accuracy in more than 3,000 patient samples. The company is also developing a blood serum-based screening test, as well as a new class of therapeutics to treat AD. Alzheimer's disease currently afflicts over 4 million Americans, and the market for AD therapy is expected to grow to 21 million patients by 2010 in the seven major pharmaceutical markets (USA, France, Germany, Italy, Spain, U.K. and Japan) according to BioPortfolio, Ltd. About PRBroadcast.com PRBroadcast.com presents detailed interviews with CEO's, Company CFO's and Analysts which provides publicly traded companies publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. with production services and distribution of their corporate messages in streaming video/audio format. Your corporate message is delivered firsthand to all major newswires, institutional and private investors, venture capitalists and buy and sell analysts, all at the click of a mouse. Using our state of the art webcasting services, PRBroadcast.com can feature and host CEO interviews, business updates, earning conference calls, analyst presentations, product launches and other special announcements directly to your audience's desktop, at minimal cost compared to video or telephone conferencing. PRBroadcast.com will provide public companies with the means and ability to reach far into the investment community with a direct message to shareholders and potential investors, through our streaming media technology, active databases of institutional and individual investors, analysts, brokerage firms and large affiliate network while providing the most impact for the communications dollar. CONTACT: For a complete corporate profile on Applied NeuroSolutions, please visit www.PRBroadcast.com or contact the Company directly at: 847.573.8000 This press release contains forward-looking statements. Applied NeuroSolutions wishes to caution the readers of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, the risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, potential competitive offerings, and access to capital. A complete disclosure of all fees paid to PRBroadcast.com, if any, is available on the Company's disclaimer page as required by Section 17B of the SEC. For further information, please visit the company's website at www.appliedneurosolutions.com, and review the company's filings with the Securities and Exchange Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion